2098545-98-1
Chemical Structure
Zeprumetostat
- CAS No.: 2098545-98-1
- Formula:C32H44N4O4
- Molecular Weight:548.72
IUPAC Name: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-(piperidin-1-ylmethyl)benzofuran-4-carboxamide
InChIKey: YLZVNQZYAYVUCW-UHFFFAOYSA-N
SMILES: O=C1NC(C)=CC(C)=C1CNC(C2=C3C=C(CN4CCCCC4)OC3=CC(N(C5CCOCC5)CC)=C2CC)=O
Biological Activity: EZH2-IN-15 (SHR2554) is a EZH2 inhibitor. EZH2-IN-15 reduces the level of histone H3 lysine 27 trimethylation (H3K27me3), regulates gene expression and releases silenced tumor suppressor genes. EZH2-IN-15 induces cell apoptosis, alters cell cycle progression and downregulates cell cycle-related proteins. EZH2-IN-15 is applicable to research related to T-cell lymphoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zeprumetostat | 99.18% | EZH2-IN-15 (SHR2554) is a EZH2 inhibitor. EZH2-IN-15 reduces the level of histone H3 lysine 27 trimethylation (H3K27me3), regulates gene expression and releases silenced tumor suppressor genes. EZH2-IN-15 induces cell apoptosis, alters cell cycle progression and downregulates cell cycle-related proteins. EZH2-IN-15 is applicable to research related to T-cell lymphoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
